Lindbrook Capital’s MGP Ingredients MGPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$19.4K Buy
661
+451
+215% +$15.1K ﹤0.01% 1364
2024
Q4
$8.27K Buy
210
+5
+2% +$272 ﹤0.01% 1751
2024
Q3
$17.1K Hold
205
﹤0.01% 1385
2024
Q2
$15.3K Buy
205
+6
+3% +$468 ﹤0.01% 1400
2024
Q1
$17.1K Hold
199
﹤0.01% 1292
2023
Q4
$19.6K Hold
199
﹤0.01% 1189
2023
Q3
$21K Hold
199
﹤0.01% 1036
2023
Q2
$21.1K Hold
199
﹤0.01% 1061
2023
Q1
$19.2K Sell
199
-8
-4% -$782 ﹤0.01% 1094
2022
Q4
$22K Sell
207
-29
-12% -$3.24K ﹤0.01% 1011
2022
Q3
$25K Buy
236
+21
+10% +$2.26K ﹤0.01% 896
2022
Q2
$22K Hold
215
﹤0.01% 934
2022
Q1
$18K Buy
215
+16
+8% +$1.29K ﹤0.01% 1050
2021
Q4
$17K Hold
199
﹤0.01% 1082
2021
Q3
$13K Hold
199
﹤0.01% 901
2021
Q2
$13K Hold
199
﹤0.01% 940
2021
Q1
$12K Hold
199
﹤0.01% 944
2020
Q4
$9K Hold
199
﹤0.01% 953
2020
Q3
$8K Hold
199
﹤0.01% 916
2020
Q2
$7K Hold
199
﹤0.01% 971
2020
Q1
$5K Buy
+199
New +$6.8K ﹤0.01% 995

Other funds holding MGPI

Lindbrook Capital's MGPI Position: Q1 2025 in Review

Lindbrook Capital increased its MGP Ingredients (MGPI) stake by 215% in Q1 2025, buying an estimated $15.1K and bringing the position to 661 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Lindbrook Capital first reported a position in MGPI in Q1 2020 and has held it in 21 quarters since. The position peaked at $25K in Q3 2022. 200 funds tracked by Wall St. Rank hold MGPI as of Q1 2025.

  • Lindbrook Capital held 661 shares of MGP Ingredients worth $19.4K as of Q1 2025.
  • Lindbrook Capital bought 451 MGP Ingredients shares in Q1 2025, an estimated $15.1K.
  • MGP Ingredients made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1364 holding.
  • Lindbrook Capital first reported a position in MGP Ingredients in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's MGP Ingredients position peaked at $25K in Q3 2022.
  • 200 funds tracked by Wall St. Rank held MGP Ingredients as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.